AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Significance: ALS can be caused by mutations in SOD1, which lead to the accumulation of misfolded SOD1 proteins and to the death of motor neurons. Here, we show that elevating MIF levels in the spinal cord can suppress misfolded SOD1 accumulation and aggregation and extend survival of mutant SOD1 mice. This study thus sheds light on the important implications of modulating MIF levels and provides insights regarding the potential therapeutic role of MIF in suppressing the selective accumulation of misfolded SOD1 in ALS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495 · cited 1×
“Among these being the formation of protein aggregates, supported by the presence of ubiquitinated insoluble inclusions in both familial and sporadic ALS cases that are SOD1 immunoreactive (15, 16), thus suggesting that the systems responsible for maintaining protein homeostasis and preventing protein aggregation are c…”
BackgroundSingle-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
Mendell, J. R., Al-Zaidy, S., Shell, R., Arnold, W. D., Rodino-Klapac, L. R., Prior, T. W., Lowes, L., Alfano, L., Berry, K., Church, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706198 · Cited by 2,381 · cited 1×
“However, this can be controlled with steroid medication treatment (67).”
BackgroundOnset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140 · cited 1×
“Specifically, hyperactivation of astrocytes (49) and microglia (50) were shown to drive disease progression in the late phase.”
BackgroundNon–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008 · cited 1×
“Although the mechanisms underlying SOD1-mediated toxicity are still not fully understood, many of the pathways that were proposed to cause motor neuron degeneration in ALS involve damage that is incurred by the accumulation of misfolded SOD1 (4), as determined by using antibodies that bind preferentially to epitopes o…”
BackgroundLi, Q., Vande Velde, C., Israelson, A., Xie, J., Bailey, A. O., Dong, M.-Q., Chun, S.-J., Roy, T., Winer, L., Yates, J. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014862107 · Cited by 169
Self-citation
Cited by
The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease
Ogunmokun, G., Dewanjee, S., Chakraborty, P., Valupadas, C., Chaudhary, A., Kolli, V., Anand, U., Vallamkondu, J., Goel, P., Paluru, H. P. R., et al. (2021) · Cells · doi:10.3390/cells10102790 · Cited by 85
Approaches to gene modulation therapy for ALS
Meijboom, K. E., & Brown, R. H. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01285-w · Cited by 38
“Intraspinal injection of AAV2/9 in neonatal SOD1G93A mice resulted in a > 50% reduction of misfolded SOD1 in the spinal cord and an increase of survival of 30 days [158].”
BackgroundXu, J.-Z., Zhou, Y.-M., Zhang, L.-L., Chen, X.-J., Yang, Y.-Y., Zhang, D., Zhu, K.-C., Kong, X.-K., Sun, L.-H., Tao, B., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01048-8 · Cited by 22
Metadata
- Authors
- Leyton-Jaimes, M. F., Kahn, J., & Israelson, A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2019-07
- Volume
- 116
- Issue
- 29
- Pages
- 14755-14760
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2953976997
- Cited by
- 42
- References
- 6
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS. https://app.cochat.ai/papers/10.1073/pnas.1904665116
- The paper
- Leyton-Jaimes, M. F., Kahn, J., & Israelson, A. (2019). AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1904665116
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.